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Abstract
Background Discrete choice experiments (DCEs) are
increasingly used in health economics to address a wide
range of health policy-related concerns.
Objective Broadly adopting the methodology of an ear-
lier systematic review of health-related DCEs, which
covered the period 2001–2008, we report whether earlier
trends continued during 2009–2012.
Methods This paper systematically reviews health-related
DCEs published between 2009 and 2012, using the same
database as the earlier published review (PubMed) to
obtain citations, and the same range of search terms.
Results A total of 179 health-related DCEs for
2009–2012 met the inclusion criteria for the review. We
found a continuing trend towards conducting DCEs
across a broader range of countries. However, the trend
towards including fewer attributes was reversed, whilst
the trend towards interview-based DCEs reversed because
of increased computer administration. The trend towards
using more flexible econometric models, including mixed
logit and latent class, has also continued. Reporting of
monetary values has fallen compared with earlier periods,
but the proportion of studies estimating trade-offs
between health outcomes and experience factors, or val-
uing outcomes in terms of utility scores, has increased,
although use of odds ratios and probabilities has
declined. The reassuring trend towards the use of more
flexible and appropriate DCE designs and econometric
methods has been reinforced by the increased use of
qualitative methods to inform DCE processes and results.
However, qualitative research methods are being used
less often to inform attribute selection, which may make
DCEs more susceptible to omitted variable bias if the
decision framework is not known prior to the research
project.
Conclusions The use of DCEs in healthcare continues to
grow dramatically, as does the scope of applications across
an expanding range of countries. There is increasing evi-
dence that more sophisticated approaches to DCE design
and analytical techniques are improving the quality of final
outputs. That said, recent evidence that the use of quali-
tative methods to inform attribute selection has declined is
of concern.
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Key Points for Decision Makers
There has been an ongoing increase in the
publication of health-related discrete choice
experiments (DCEs), which can inform policy
making: during 1990–2000 there were 34 health-
related DCEs meeting reviewer inclusion criteria
(approximately 3 per year); for 2001–2008, the
figure was 114 health-related DCEs (approximately
14 per year); whilst for 2009–2012, 179 health-
related DCEs met our inclusion criteria
(approximately 45 per year).
For 2009–2012, we found a continuing trend towards
conducting DCEs across a broader range of
countries. Consequently, DCE results can influence
decisions in a wider range of geographical settings.
There is evidence of improvement in DCE design
and analysis. For example, an increasing proportion
of DCEs take interactions as well as main effects into
consideration as part of their designs. Also, the
econometric models used to analyze DCE data
increasingly cater for preference heterogeneity using
either mixed logit, latent class models, or
hierarchical Bayesian models.
1 Introduction
Discrete choice experiments (DCEs) are increasingly used
in health economics to address a wide range of health
policy-related concerns. The approach draws its micro-
economic foundations from the characteristics theory of
demand [1] and random utility theory (RUT) [2]. The
characteristics theory of demand assumes that goods, ser-
vices, or types of healthcare provision can be valued in
terms of their constituent characteristics (otherwise known
as attributes). DCEs involve respondents making a number
of stated preference choices in response to DCE questions.
According to RUT, respondents are assumed to act in a
utility maximizing manner and make choices contingent
upon the levels of attributes in DCE scenarios. Therefore,
choice data obtained from respondents’ stated preferences
can be analyzed using econometric methods compatible
with RUT. If the specified attributes are significantly
related to respondent choices, findings from data analysis
should confer information relating to how the average
respondent’s utility (or willingness to pay) is affected by
changes in the levels of attributes. RUT assumes that
respondent utility can be decomposed into a systematic
component, which is a function of attributes and their
levels, and a random component, which is an error term in
the regression equation related to unmeasured preference
variation. Published DCEs in healthcare are usually com-
patible with RUT [3–5], in the sense that they adopt a
methodology consistent with RUT.
Although reviews and commentaries have been pub-
lished of healthcare-related DCEs for specific clinical
contexts or health-related concerns [6–8], and conjoint
analyses more broadly [9], the most comprehensive
reviews of the healthcare DCE literature cover the periods
1990–2000 [4] and 2001–2008 [3]. This paper updates
those earlier systematic reviews to cover the period
2009–2012, and considers how key aspects of the design
and application of DCEs have changed across the three
periods.
2 Literature Review
2.1 Methods
This review builds upon the earlier systematic reviews [3,
4]. It focuses on the 2009–2012 literature, and was derived
from the literature in the sense that it replicates the meth-
odology of the most recent review [3]. Although further
checklists or commentaries on best practice [10–16] have
been developed in recent years, these did not require fun-
damental changes to the approach to reviewing the DCE
literature. Moreover, some of these checklists or commen-
taries [12–14] had already informed the development of the
criteria deployed in the 2001–2008 review, whilst others
served to confirm that our review encompassed appropriate
criteria [11, 15, 16]. However, we did feel that the range of
information extracted in relation to preference heterogene-
ity models such as mixed logit could be improved upon, and
so we also gathered additional information on the distribu-
tional assumptions deployed when mixed logit was applied,
and the number of Halton draws that were specified for
replications. Searches were restricted to the PubMed search
engine, replicating the approach of the most recent review
[3], and used the same search terms, including ‘conjoint’,
‘conjoint analysis’, ‘conjoint measurement’, ‘conjoint
studies’, ‘conjoint choice experiment’, ‘part-worth utilities’,
‘functional measurement’, ‘paired comparisons’, ‘pairwise
choices’, ‘discrete choice experiment’, ‘dce’, ‘discrete
choice mode(l)ling’, ‘discrete choice conjoint experiment’,
and ‘stated preference’. Initial searches were conducted in
September 2011, and then updated in March 2012 and
August 2013 to ensure that all 2011 and 2012 papers were
included. Moreover, for the period 2009–2012, we also
allowed for the inclusion criteria to include a small number
of best–worst scaling (BWS) DCEs/technical theoretical
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papers, as long as they generated health-related DCE results
alongside BWS results. We included case 3 type BWS
studies [17, 18] in the main review because, unlike case 1
and 2 BWS studies, these involve a comparison between
two or more profiles [17]. This is despite the fact that case 3
BWS studies do differ from mainstream DCEs, because
respondents choose the least attractive profile in addition to
the most attractive one [17].
At the request of one of the peer reviewers, we also
reviewed health-related adaptive conjoint analysis (ACA)
and adaptive choice-based conjoint (ACBC) studies, and
any menu-based conjoint analyses that had been published
between 1990 and 2012. Such analyses had been excluded
from the previous reviews [3, 4].
3 Search Results
Following the PubMed searches using the aforementioned
search terms, we sourced 12 ACA/ACBC analyses for the
period 2009–2012 [19–30]; 14 ACA/ACBC analyses for the
period 2001–2008 [31–44], and no analyses of these types
for the period 1990–2000. However, we reviewed these
separately and deposited the data in an electronic supple-
ment (see the Electronic Supplementary Material) because
these analyses adopt a fundamentally different approach to
valuing attributes to mainstream DCE analyses, and we
wanted to ensure that data in the main body of the paper
were in step with inclusion criteria adopted for the previous
reviews [3, 4], which had excluded such analyses.
Overall, 179 analyses were identified as meeting the
inclusion criteria for the main review, i.e. health-related
DCEs or case 3 BWS analyses published in the English
language. Each paper was read carefully and key data
extracted systematically in the sense of evaluating them
against a checklist of pre-established criteria, which largely
corresponded to those used in the most recent of the pre-
vious reviews [3]. The data are summarized in the fol-
lowing Sects. 3.1–7.2. In Table 1, we provide further
information relating to the definitions and other details of
analyses in each of the categories.
Category A covers 25 separate analyses in 24 papers
[45–67]; Category B includes 13 analyses in 13 papers
[68–80]; Category C encompasses 81 analyses in 81 papers
[81–162]; Category D relates to four analyses in four
papers [163–166]; Category E covers 11 different analyses
in eight papers [167–174]; Category F encompasses 24
analyses in 23 papers [47, 71, 72, 82, 86, 107, 119, 161,
175–189]; Category G includes 24 analyses in 23 papers
[53, 62, 70, 72, 103, 122, 133, 139, 141, 143, 145, 190–
201]; and Category H relates to ‘other’ analyses, and there
are 21 ‘other’ analyses in 21 papers [63, 90, 103, 137, 145,
158, 159, 197, 202–214]. In Sects. 3.1–7.2, key findings are
summarized in graphs. In the following text, we highlight
changes that are of a reasonable magnitude and may be
regarded as of significance.
3.1 Number of Discrete Choice Experiment (DCE)
Analyses per Year
Figure 1 summarizes the average number of DCEs pub-
lished per year across the three review periods. The
2001–2008 review [3] noted that the number of published
applications of DCEs in healthcare rose from a mean of 3
per year (1990–2000) to a mean of 14 per year
(2001–2008). Our review for 2009–2012 showed that the
average number of analyses rose again to 45 per year
(2009–2012), a marked increase, and peaked at 74 in 2012.
3.2 DCE Studies Country of Origin
Figure 2 indicates the proportion of analyses emanating
from different countries during the three time periods. The
2001–2008 review noted that the UK remained the main
source of DCEs in healthcare. However, UK dominance
has been eroded considerably since then (see Fig. 2). The
proportion of analyses emanating from the UK has con-
tinued to fall, from 59 % in 1990–2000 to 48 % in
2001–2008, and to 22 % during 2009–2012. Moreover, the
proportion of analyses emanating from Australia (AUS)
has fallen from 18 % in 1990–2000 to 11 % in 2001–2008,
and to 7 % in 2009–2012.
Comparing 2001–2008 with 2009–2012, an increased
proportion of analyses now originate in the USA, Canada
(CAN), Denmark (DNK), the Netherlands (NLD), and
Germany (DEU). There was also an increase in analyses
coming from ‘other’ countries (11 % in 2001–2008 com-
pared with 25 % in 2009–2012), reflecting an increasing
trend towards applying DCEs across a range of high-,
middle-, and low-income countries1.
3.3 The Number of Attributes Included in DCE Studies
Figure 3 provides information on the number of attributes
included in DCE analyses across the three time periods.
The most noteworthy change includes the fact that the
proportion of analyses with four or five attributes rose from
29 % in 1990–2000 to 44 % in 2001–2008, but fell back to
32 % in 2009–2012. There was also an increase in the
number of DCEs with between seven and nine attributes:
12 % in 1990–2000, 13 % in 2001–2008, increasing to
22 % in 2009–2012.
1 Lower income countries in 2008–2012 included Kenya, South
Africa, Thailand, China, Ghana, Vietnam, Ethiopia, Peru, Ukraine,
India, Cuba, Nepal, Turkey, and Burkina Faso.
Discrete Choice Experiments in Health Economics 885
T
a
b
le
1
D
efi
n
it
io
n
s,
an
d
d
et
ai
ls
o
f
to
ta
l
n
u
m
b
er
o
f
an
al
y
se
s
in
ea
ch
ca
te
g
o
ry
C
at
eg
o
ry
D
efi
n
it
io
n
o
f
ca
te
g
o
ry
N
u
m
b
er
o
f
an
al
y
se
s,
an
d
n
u
m
b
er
o
f
p
ap
er
s
th
e
an
al
y
se
s
ar
e
co
n
ta
in
ed
in
N
u
m
b
er
o
f
p
ap
er
s
p
er
ca
te
g
o
ry
al
so
co
v
er
ed
b
y
o
th
er
ca
te
g
o
ri
es
an
d
ci
ta
ti
o
n
d
et
ai
ls
O
th
er
ex
p
la
n
at
o
ry
in
fo
rm
at
io
n
A
P
at
ie
n
t
o
r
co
n
su
m
er
ex
p
er
ie
n
ce
fa
ct
o
rs
2
5
(2
4
)
3
[4
7
,
5
3
,
6
2
]
W
it
h
in
th
is
ca
te
g
o
ry
,
a
p
ap
er
b
y
D
am
m
an
et
al
.
[4
6
]
co
n
ta
in
s
tw
o
an
al
y
se
s,
o
n
e
re
la
ti
n
g
to
k
n
ee
s,
an
d
an
o
th
er
re
la
ti
n
g
to
ca
ta
ra
ct
s;
an
an
al
y
si
s
b
y
G
o
o
d
al
l
et
al
.
[5
1
]
co
n
ta
in
s
tw
o
an
al
y
se
s,
o
n
e
re
la
ti
n
g
to
p
at
ie
n
t
p
re
fe
re
n
ce
s
an
d
an
o
th
er
re
la
ti
n
g
to
ca
re
r
p
re
fe
re
n
ce
s.
T
h
er
e
ar
e
al
so
tw
o
p
ap
er
s
ci
te
d
fo
r
o
n
e
an
al
y
si
s
b
y
N
ai
k
-P
an
v
el
k
ar
et
al
.
[6
0
,
6
1
]
B
V
al
u
in
g
h
ea
lt
h
o
u
tc
o
m
es
1
3
(1
3
)
2
[7
0
,
7
2
]
N
o
t
ap
p
li
ca
b
le
C
In
v
es
ti
g
at
in
g
tr
ad
e-
o
ff
s
b
et
w
ee
n
h
ea
lt
h
o
u
tc
o
m
es
an
d
p
at
ie
n
t
o
r
co
n
su
m
er
ex
p
er
ie
n
ce
fa
ct
o
rs
8
1
(8
1
)
1
3
[8
2
,
9
0
,
1
0
3
,
1
0
7
,
1
1
9
,
1
3
3
,
1
3
7
,
1
3
9
,
1
4
1
,
1
4
3
,
1
4
6
,
1
5
8
,
1
6
1
]
W
it
h
in
th
is
ca
te
g
o
ry
th
er
e
ar
e
tw
o
p
ap
er
s
b
y
M
o
rt
o
n
et
al
.
[1
3
1
,
1
3
2
],
w
h
ic
h
h
av
e
b
ee
n
re
v
ie
w
ed
as
o
n
e
an
al
y
si
s.
H
o
w
ev
er
,
a
p
ap
er
b
y
R
eg
ie
r
et
al
.
[1
4
3
]
co
n
ta
in
ed
tw
o
an
al
y
se
s
(o
n
e
re
la
ti
n
g
to
fu
n
g
al
tr
ea
tm
en
t,
an
d
th
e
o
th
er
re
la
ti
n
g
to
b
ac
te
ri
al
is
su
es
)
D
E
st
im
at
in
g
u
ti
li
ty
w
ei
g
h
ts
w
it
h
in
th
e
q
u
al
it
y
-a
d
ju
st
ed
li
fe
-y
ea
r
fr
am
ew
o
rk
4
(4
)
N
o
t
ap
p
li
ca
b
le
N
o
t
ap
p
li
ca
b
le
E
Jo
b
ch
o
ic
es
1
1
(8
)
N
o
t
ap
p
li
ca
b
le
W
it
h
in
th
is
ca
te
g
o
ry
,
a
p
ap
er
b
y
R
o
ck
er
s
et
al
.
[1
7
3
]
co
n
ta
in
s
fo
u
r
an
al
y
se
s,
o
n
e
re
la
ti
n
g
to
m
ed
ic
al
st
u
d
en
t
p
re
fe
re
n
ce
s,
an
o
th
er
re
la
ti
n
g
to
n
u
rs
in
g
st
u
d
en
t
p
re
fe
re
n
ce
s,
an
o
th
er
re
la
ti
n
g
to
p
h
ar
m
ac
y
st
u
d
en
t
p
re
fe
re
n
ce
s,
an
d
an
o
th
er
re
la
ti
n
g
to
sc
ie
n
ce
st
u
d
en
t
p
re
fe
re
n
ce
s
F
D
ev
el
o
p
in
g
p
ri
o
ri
ty
se
tt
in
g
m
ec
h
an
is
m
2
4
(2
3
)
8
[4
7
,
7
1
,
7
2
,
8
2
,
8
6
,
1
0
7
,
1
1
9
,
1
6
1
]
W
it
h
in
th
is
ca
te
g
o
ry
,
th
e
p
ap
er
b
y
P
ro
m
b
er
g
er
et
al
.
[1
8
4
]
co
n
ta
in
s
tw
o
se
p
ar
at
e
an
al
y
se
s
fo
r
ev
al
u
at
io
n
G
H
ea
lt
h
p
ro
fe
ss
io
n
al
s
p
re
fe
re
n
ce
s
fo
r
tr
ea
tm
en
t
an
d
sc
re
en
in
g
o
p
ti
o
n
s
2
4
(2
3
)
1
0
[5
3
,
6
2
,
7
0
,
7
2
,
1
0
3
,
1
3
3
,
1
3
9
,
1
4
1
,
1
4
3
,
1
4
5
]
W
it
h
in
th
is
ca
te
g
o
ry
,
th
e
p
ap
er
b
y
R
eg
ie
r
et
al
.
[1
4
3
]
co
n
ta
in
s
tw
o
se
p
ar
at
e
an
al
y
se
s
fo
r
ev
al
u
at
io
n
.
O
n
e
o
f
th
es
e
re
la
te
s
to
fu
n
g
al
in
fe
ct
io
n
an
d
th
e
o
th
er
re
la
te
s
to
b
ac
te
ri
al
in
fe
ct
io
n
H
O
th
er
2
1
(2
1
)
8
[6
3
,
9
0
,
1
0
3
,
1
3
7
,
1
4
5
,
1
5
8
,
1
5
9
,
1
9
7
]
N
o
t
ap
p
li
ca
b
le
886 M. D. Clark et al.
The proportion of analyses with more than ten attributes
fell from 12 % in 1990–2000 to 2 % in 2001–2008, and
remained at that level in 2009–2012.
3.4 Domains of DCE Attributes
Figure 4 provides information on the proportion of DCEs
encompassing different domains. The main noteworthy
changes include the fact that the proportion of analyses
with a domain related to time fluctuated; it was 74 % in
1990–2000, in 2001–2008 it fell to 51 %, before rising
again to 65 % in 2009–2012.
The proportion of DCEs including a measure of risk rose
in the most recent period from 35 % in 1990–2000 and
31 % in 2001–2008, to 57 % in 2009–2012.
The proportion of analyses with a healthcare (HC)
domain also fluctuated: 82 % in 1990–2000, falling to
69 % during 2001–2008, and increasing to 72 % in
2009–2012. At the same time, the proportion of analyses
with attributes relating to ‘other’ domains, not encom-
passed by existing categories, increased from 9 % in
1990–2000 to 15 % in 2001–2008, and 47 % in
2009–2012. Additional categories in Fig. 4 include a
monetary domain (Money) and a health status domain
(HS).
3.5 The Number of Questions Posed by DCEs
Figure 5 provides information on the number of choice
tasks posed by DCEs. The main noteworthy trends are as
follows. The proportion of DCE analyses posing eight or
fewer choices (\9) was 38 % in 1990–2000, 39 % in
2001–2008, but fell back to 22 % in 2009–2012. In con-
trast, the proportion of analyses with 9–16 choices was
53 % in 1990–2000, falling to 38 % during 2001–2008,
and rising to 62 % during 2009–2012. The proportion of
analyses with more than 16 choices ([16) rose initially and
then stabilized (6 % in 1990–2000, 18 % in 2001–2008,
and 15 % in 2009–2012).
Fig. 3 Number of attributes
Fig. 4 Attribute domains. HC healthcare, HS health status
Fig. 1 Average number of DCE studies/year. DCE discrete choice
experiment
Fig. 2 Country of origin. AUS Australia, CAN Canada, DEU
Germany, DNK Denmark, NLD the Netherlands
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3.6 DCE Survey Administration
Figure 6 provides information on the different modes of
administering DCEs. Since 1990, there has been a trend
away from self-completed pen/paper questionnaires. The
proportion of analyses using self-completed questionnaires
(Survey) was 79 % in 1990–2000, falling to 67 % in
2001–2008, and then further to 48 % in 2009–2012. The
proportion of interviewer-administered DCEs (Interview)
was 9 % in 1990–2000, rising to 19 % in 2001–2008, and
was 17 % in 2009–2012.
Overall, there has been a trend towards DCEs involving
computerized administration (Computer), sometimes
involving internet surveys, over the last 20 years. There
have been improvements in computer technology, com-
bined with the increased use of computers by the wider
population. This has made accessing DCE respondent
samples using computers easier. Moreover, the ease with
which DCE samples can be accessed using computers and
the internet partly explains the trend towards increased use
of DCEs since 1990. During 1990–2000, 9 % of analyses
involved computerized administration; the figure was 11 %
in 2001–2008 and then rose sharply to 40 % during
2009–2012. As depicted in Fig. 6, a small proportion of
analyses failed to report (Not reported) the form of survey
administration in each period.
4 DCE Experimental Design and Choice Set
Construction
A good discussion of some of the relevant issues relating to
DCE design is contained in the review by de Bekker-Grob
et al. [3], so in the interests of brevity, we refer the reader
to that paper and to another key citation [11].
4.1 Design Plan
Figure 7 depicts information on the different types of
design plans. The most noteworthy trends are as follows.
The proportion of analyses involving full factorial (Full
fact.) DCE designs fell from 12 % in 1990–2000 to 0 % in
2001–2008, and then rose again to 6 % during 2009–2012.
In the period 1990–2000, 74 % of analyses adopted a
fractional factorial design (Fractional fact.), a proportion
that rose to 100 % in 2001–2008, but then decreased to
88 % in 2009–2012. Overall, 15 % of analyses did not
clearly report their design type (Not reported) in
1990–2000, a proportion that fell to 0 % in 2001–2008, but
then rose again to 7 % during 2009–2012.
Overall in 1990–2000, 74 % of DCE analyses involved
a ‘main effects’ design (Main Eff.), and this proportion
rose to 89 % during 2001–2008, but then fell back to 54 %
in 2009–2012. Therefore, as with the baseline and
2001–2008 reviews, ‘main effects’ designs remain the
dominant type of design in published DCE studies. In
1990–2000, 6 % of analyses catered for interaction effects
alongside main effects (Main & Int. Eff.); the proportion
was 5 % in 2001–2008, and increased to 13 % in
2009–2012. In some cases, a design plan was not appli-
cable, whilst in others, it was not reported.
Fig. 6 Survey administration
Fig. 7 Design plan. Eff. effects, fact. factorial, Int. interaction
Fig. 5 Number of choice tasks
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4.2 Use of Software Packages to Design DCEs
Figure 8 summarizes information on the use of different
software packages for the design of the DCEs. The most
noteworthy trends are that the use of a software package
to design DCEs remained steady throughout the years
(Fig. 9).
Figure 8 shows there seems to have been a general trend
away from using SPEED over the period as new software
has become available. In 1990–2000, 38 % of analyses
used SPEED; this proportion fell to 19 % in 2001–2008,
and to 4 % in 2009–2012.
The SAS package (which can provide D-efficient
designs) has become increasingly popular. Recorded use
rose from 0 % in 1990–2000 to 12 % in 2001–2008, and
21 % in 2009–2012. Use of SPSS did not change that
much. The use of Sawtooth software fluctuated; 6 % of
analyses used this software in 1990–2000, 4 % used it in
2001–2008, and 13 % used it in 2009–2012. The use of
‘other’ software was also low (6 % in 1990–2000, 0 % in
2001–2008, and 7 % in 2009–20122), and only a small
proportion of analyses in each period failed to provide
information on type of software (No details).
4.3 Use of Design Catalogues, Websites, and Expert
Advice to Design DCE Questionnaires
Figure 9 depicts information on the use of software, design
catalogues, websites, and experts to inform DCE design
and whether this was not reported. Figure 9 shows that
there have not been any particularly large changes in the
use of these over the three periods.
4.4 Methods Used to Create Choice Sets
Figure 10 depicts information on the use of different
methods to create choice sets. The most noteworthy trends
are as follows. In 1990–2000, 9 % of analyses reported
designs that involved orthogonal arrays with single pro-
files, i.e. binary choices (Single profiles); the proportion
was 11 % in 2001–2008, but fell to 1 % in 2009–2012. Use
of orthogonal arrays with random pairing (RP) was more
common, but has fallen over time; in 1990–2000 it was
applied in 53 % of analyses, falling to 17 % in 2001–2008
and 10 % in 2009–2012.
Analyses involving orthogonal arrays with pairing with
a constant comparator constituted approximately one in
five designs in earlier periods, 18 % in 1990–2000 and
20 % in 2001–2008, before falling to 3 % in 2009–2012. In
1990–2000, none of the analyses involved orthogonal
arrays with a foldover design, but this proportion rose to
10 % in 2001–2008 and 17 % in 2009–2012. Very few
analyses in each period used a foldover design with random
pairing (Foldover RP), or pragmatically chosen designs.
Similarly, there has been a general trend towards D-effi-
cient designs (D-efficiency), rising from 0 % in 1990–2000
to 12 % of studies in 2001–2008, and 30 % of studies in
2009–2012. The proportion of analyses that did not clearly
report (Not reported) the methods used to create choice sets
2 ‘Other’ packages used included Gauss for two analyses; nGene (a
Bayesian efficient design) for four analyses; and the statistical design
procedure Gosset for one analysis; a D-efficient design advocated by
Rose and Bliemer for one analysis; STATA for one design; a design
described as ‘‘an experimental design algorithm optimizing orthog-
onality, attribute balance, and efficiency’’ for one design; and Street
and Burgess Software for one design.
Fig. 9 Design source
Fig. 8 Software packages
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rose from 9 % in 1990–2000 to 28 % in 2001–2008 and
stabilized at 26 % in 2009–2012, whilst in one period
(2009–2012), 11 % of analyses used ‘other’ methods to
create choice sets.
5 Estimation Procedures
As there is a good explanation of RUT, alternative DCE
econometric models, and the appropriateness of different
models for different DCE applications in the earlier review
paper, we refer readers to Sects. 5.1–5.3 of that paper in the
interests of brevity [3]. Figure 11 depicts information on the
different estimation methods. The most noteworthy trends
are described in the sections below. In Fig. 11 details of the
econometric estimation methods used are depicted.
5.1 Use of Probit, Random Effects Probit, Logit,
and Random Effects Logit
As previously reported, early DCE studies, i.e. those pub-
lished in 1990–2000, seemed to focus upon applying either
binary choice or ‘forced choice’ DCEs [4]. So, for exam-
ple, in 1990–2000, 18 % of analyses used probit; this
proportion fell to 7 % in 2001–2008, and fell further to 2 %
in 2009–2012. Similarly, in 1990–2000, 53 % of analyses
used random effects probit (RE probit), falling to 41 % in
2001–2008, and then further to 10 % in 2009–2012. The
proportion of logit analyses was 3 % in 1990–2000, rising
to 11 % in 2001–2008, and was 10 % in 2009–2012, and
relatively few analyses used random effects logit (RE
Logit) in each time period.
5.2 Use of Multinomial Logit
The overall decline in the use of logit, probit and random
effects probit reported above has been offset by an
increased use of multinomial logit (MNL) analyses, which
are sometimes otherwise known as conditional logit anal-
yses. These analyses have the advantage that they can cater
for more than two response options, and they can also
allow respondents to ‘opt-out’ from making a decision.
Sometimes such models may also be associated with better
‘goodness of fit’ than some other econometric models.
During 1990–2000, 18 % of studies used MNL, 22 % used
it during 2001–2008, rising to 44 % during 2009–2012.
5.3 Use of Nested Logit
During the period 2001–2008, a small shift towards use of
nested logit (NL), a technique that relaxes the indepen-
dence of irrelevant alternatives (IIA), was observed [3]. It
was applied in 4 % of studies during 2001–2008, up from
0 % in 1990–2000. For the period 2009–2012, the pro-
portion remained low at 2 % of studies.
a
b
Fig. 11 a Estimation procedures. b Distributional assumptions.
Distrib. distributions, LCM latent class model, MNL multinomial
logit, MXL/RPL mixed logit/random parameters logit, NL nested logit,
RE random effects
Fig. 10 Methods to create choice sets. RP random pairing
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5.4 Models Applicable When There is Preference
Heterogeneity
During 1990–2000, only 3 % of studies used mixed logit/
random parameters logit (MXL/RPL); by 2001–2008, 5 %
of analyses used MXL/RPL. During the period 2009–2012,
there was a clear trend towards increased use of MXL/RPL,
and 21 % of analyses utilized the technique. All the anal-
yses involving MXL/RPL found evidence of preference
heterogeneity. Ideally, when MXL/RPL analyses are sub-
mitted for publication, details of the number of replications
(sometimes described as ‘Halton draws’) should be pro-
vided, as results can be sensitive to the number of repli-
cations. This occurred in 0 % of MXL/RPL analyses in
1990–2000, 67 % in 2001–2008, and 47 % in 2009–2012.
Unlike latent class models (LCM), MXL/RPL analyses
make distributional assumptions for random parameters
(Fig. 11b). Not all MXL/RPL analyses indicate what these
are. Indeed, in 1990–2000, 100 % of analyses failed to
indicate them. In 2001–2008, 17 % failed to provide this
information, and in 2009–2012, 47 % failed to provide this
information. When such information was provided, analy-
ses usually indicated they had assumed normal distribu-
tions for random parameters: 0 % in 1990–2000, 83 % in
2001–2008, and 53 % in 2009–2012. However, in 17 % of
cases in 2001–2008, and 8 % in 2009–2012, models
assuming logarithmic distributions for random parameters
were also reported alongside results from models assuming
normal distributions for random parameters. Also, one
study [115] used a mixed logit hierarchical Bayesian model
(MLHB), an extension of mixed logit modeling. Another
analysis used what it described as a Bayesian-like approach
similar to mixed logit [80]. Sometimes hierarchical
Bayesian analysis has also been used without mixed logit
[48, 70, 114, 204]. A small proportion of analyses did not
report the estimation procedure used.
During the early period (1990–2000), no study used
LCM. During the period 2001–2008, one study (1 %) used
LCM, and the study also found evidence of preference
heterogeneity [216]. During 2009–2012, five analyses
(3 %) [57, 61, 129, 168, 204] used LCM, and they all
identified evidence of preference heterogeneity.
A few analyses used ‘other’ estimation procedures. In
1990–2000, this was the case for 3 % of analyses; the
proportion was 4 % of analyses in 2001–2008 and 17 % of
analyses in 2009–20123.
6 Validity
6.1 Validity Checks
The proportions of studies that used different validity tests
are depicted in Fig. 12.
The most noteworthy trends are as follows. Tests of
external validity (External) are particularly valuable
because stated preferences from DCEs can then be com-
pared with revealed preferences. However, there is often
little scope to conduct tests of external validity (particularly
if DCEs are applied in the context of state funded health-
care provision). This may explain why none of the analyses
contained a test for external validity during 1990–2000.
The proportion rose to 1/114 analyses (1 %) in 2001–2008
as there was a study [217] that compared doctors’ pre-
scribing decisions in relation to prescriptions for alcohol-
ism with the preferences they expressed in a DCE. For the
most recent period (2009–2011), only one [144] analysis
(\1 %) contained a test of external validity.
3 ‘Other’ methods used in 2009–2012 included weighted probit [68];
OLS with a hetero-robust covariance matrix estimator [192]; a
method described as ‘‘modelling including interaction effects’’ [45];
Cox’s proportional hazards model with time-dependent covariate
[105]; weighted least squares regression to estimate utility weights
[105]; multivariate ordered probit to estimate conjoint utility param-
eters [76]; mixed logit with hierarchical Bayesian modeling and
ordered probit [115]; generalized estimated equations [109, 125];
random parameter logit estimated using a hierarchical Bayesian
algorithim [208]; conditional logit and parameter weighting functions
[160]; a series of multivariate regressions [50, 65]; a method
described as Bayesian-like for preference weights [80]; OLS [87];
hierarchical Bayesian analysis [48, 70, 114, 205, 212]; multinomial
exploded logit [177]; Firth’s unbiased estimator [193]; combined
conditional logit and ranked logit model [127]; multivariate multi-
level logistic regression [46]; generalized multinomial logit [119];
mixed effect logistic regression [184], error components mixed logit
analysis [63]; a combination of Bayes theorem, Monte Carlo Markov
chain procedure and the Metropolis Hastings algorithm [182]; and
logistic and probit regression using cluster-robust standard error (SE),
random effects and GEE and multinomial logistic and probit
regressions with cluster-robust SE and random effects multinomial
logistic model and probit model with cluster-robust SE treating the
choices from two stages as two correlated binary outcomes [94].Fig. 12 Validity checks. Exp. expansion
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Most analyses included tests for internal theoretical
validity (Theoretic). Overall, 65 % of analyses in
1990–2000 included these tests, with the proportion falling
to 56 % in 2001–2008, and it was 60 % in 2009–2012.
Such tests involve an assessment of whether coefficients
appear to move in line with prior expectations, and studies
generally reported that this was the case.
Tests for non-satiation were less frequently reported. For
the period 1990–2000, 44 % of analyses contained such a
test; the proportion was 49 % in 2001–2008, before falling
to 21 % in 2009–2012. The decline in the use of such tests
probably reflects concerns that they tend to be passed, so
that they are a relatively weak test of validity. Also, in an
influential paper [218], it has been argued that preferences
that may appear to be ‘irrational’ may in reality be com-
patible with some form of rationality. Therefore, to delete
such responses may be inappropriate, so the decline in the
use of such tests may reflect good practice.
If tests of transitivity could readily be applied using
DCEs, the information yielded might be more useful.
However, they cannot always be readily applied, which is
presumably why over the period 1990–2000 only 9 % of
analyses contained a transitivity test; in 2001–2008, 4 % of
analyses contained such a test, and during 2009–2012, 1 %
of analyses contained a transitivity test. During 1990–2000,
none of the analyses contained a test relating to Sen’s
expansion and contraction properties (Sen’s exp. & con-
traction); the proportion was 2 % of analyses during
2001–2008, and 1 % of analyses during 2009–2012. Use of
a test for internal compensatory decision making (Com-
pensatory) [3] was much more frequent. In 1990–2000,
35 % of analyses involved such a test; the value for
2001–2008 was 32 % of analyses, but in 2009–2012, this
declined to 14 % of analyses.
6.2 Use of Qualitative Methods to Enhance DCE
Processes and Results
Information on the use of qualitative methods to enhance
DCE processes and results is depicted in Fig. 13. In
1990–2000, 18 % of analyses used qualitative methods to
inform attribute selection (Attrib. selection), rising to 69 %
of analyses in 2001–2008, before declining to 51 % of
analyses in 2009–2012. This is potentially a worrying trend
because if the selection of attributes is not properly
grounded in qualitative research, then inappropriate attri-
butes may be specified and appropriate attributes may be
omitted (triggering omitted variable bias). It would be of
little concern, however, if the recent reduction in the use of
qualitative methods to inform attribute selection was trig-
gered by the wider use of DCEs in contexts in which the
decision framework is already known (for example, if
DCEs are conducted alongside clinical trials).
In contrast, the use of qualitative methods to inform
attribute level selection (Level selection) increased; the
proportion was 18 % of analyses in 1990–2000, increasing
to 33 % in 2001–2008, before increasing again to 40 % in
2009–2012. The use of a pre-testing questionnaire (Pre-
testing) fluctuated over time; it was applied in 47 % of
analyses in 1990–2000, just 32 % of analyses in
2001–2008, but was applied in 41 % of analyses in
2009–2012. The use of debriefing choices (Debriefing) to
help strengthen understanding increased from 0 % of
analyses in 1990–2000 to 4 % of analyses in 2001–2008,
and 8 % of analyses during 2009–2012.
7 Areas of Application and Outcome Measures
7.1 Areas of Application
As indicated by de Bekker-Grob et al. [3], although DCEs
had originally been introduced into health economics pri-
marily in order to value patient experience [219], there was
clear evidence that the application of DCEs had broadened
considerably by 2000–2008 [3]. Moreover, this trend
continued into 2009–2012. Figure 14 summarizes the rel-
evant data (for the definitions of categories A, B, C, D, E,
F, G, and H, refer to Table 1).
The main noteworthy trends are as follows. In
1990–2000, 35 % of analyses had a main study objective
that involved valuing experience factors (Category A). The
proportion was the same in 2001–2008, as 35 % of anal-
yses had the same main study objective. However, during
2009–2012, this proportion fell to 12 % of analyses. In
contrast, the proportion of DCEs exploring trade-offs
between health outcomes and experience factors has risen
steadily (Category C). In 1990–2000, 41 % of analyses had
this as a primary objective; during 2001–2008, the
Fig. 13 Use of qualitative methods. Attrib. attribute.
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proportion was 33 % of analyses, increasing further to
44 % of analyses in 2009–2012. This reflects a shift from
examining patient experience factors (Category A) in iso-
lation (down from 35 % in 2001–2008 to 12 % in
2009–2012) towards estimating trade-offs between health
outcomes and experience factors (Category C), which
increased from 33 % of analyses in 2001–2008 to 41 % in
2009–2012. The latter category (Category C) also includes
the estimation of trade-offs for non-patient groups, whereas
the former (Category A) is specific to patient respondents.
In 1990–2000, no analysis included a main objective of
estimating utility weights within a quality-adjusted life-
year (QALY) framework (Category D). During
2001–2008, 2 % of analyses had this as the main objective.
These two analyses used DCEs as an alternative to standard
gamble (SG) and time trade-off (TTO) to estimate utility
weights within a QALY framework [220, 221]. More
recently, there has been some further work in this area. In
2009–2012, 2 % of analyses had this as their main objec-
tive, reflecting some interest in this research agenda. One
of these analyses [165] looked at deriving distributional
weights for QALYs using DCEs; another [164] used DCEs
to quantify EQ-5D health states, whilst another [163]
explored whether a DCE that resembles TTO exercises is
able to estimate consistent values on the health utility scale
for the EQ-5D. A further analysis compared case 3 BWS
DCE analysis with WTP analysis [166].
A small proportion of DCEs have had a primary
objective of evaluating job choices, human resource policy
(Category E), or developing priority setting frameworks
(Category F), and values for these categories did not
exhibit much change (see Fig. 14).
During 1990–2000, 3 % of analyses had the main
objective of establishing health professionals’ preferences
(Category G); this rose to 15 % in 2001–2008, before
falling slightly to 12 % in 2009–2012. In 1990–2000, 0/34
analyses (0 %) had an ‘other’ (Category H) main objective;
this rose to 4 % of analyses in 2001–2008, before rising
again to 10 % of analyses in 2009–20124.
7.2 Outcome Measures
Information on trends relating to ‘main outputs’ is depicted
in Fig. 15. In the past, DCEs often expressed outputs in
terms of a primary outcome measure of ‘per WTP unit’ or
‘per time unit’. In 1990–2000, 29 % of analyses used the
‘per WTP unit’ (WTP) outcome measure, increasing to
39 % of analyses in 2001–2008; however, in 2009–2012,
the proportion was only 31 % of analyses. The use of ‘per
unit of time’ (Time) as an outcome measure has also
declined markedly over the period. During 1990–2000,
29 % of analyses used this outcome measure; in
2001–2008, the proportion was 20 % of analyses, and it
declined further to 3 % of analyses in 2009–2012.
The proportion of DCEs using ‘per risk unit’ (Risk) as a
primary outcome is low, and this has fluctuated little over
the period (see Fig. 15). Only a minority of analyses use
monetary welfare measures (Money) as the primary out-
come measure, and this proportion has fallen in propor-
tionate terms over time. During 1990–2000, 15 % of
analyses involved a money welfare measure; during
2001–2008, the proportion was 12 % of analyses; and
during 2009–2012, the proportion was 2 % of analyses.
4 In 2009–2012, one study explored how changing the number of
responses elicited from respondents might affect estimates of WTP
[204]; another looked at parents’ preferences for management of
attention-deficit hyperactivity disorder [206]; one study looked at
general public preferences for long-term care [137]; another two
studies looked at preferences for human papillomavirus vaccine, one
case looking a societal preferences [207] and the other [63] looking at
mothers’ preferences; another study looked at the valuation of
diagnostic testing for idiopathic developmental disability by the
general population [208]; another looked at various stakeholder
groups’ preferences for coagulation factor concentrates to treat
hemophilia [145]; one study looked at general public preferences for
tele-endocopy services [158]; another compared Dutch and German
preferences for health insurance amongst their populations [214]; one
paper looked at public and decision maker preferences for pharma-
ceutical subsidy decisions [215]; one study explored how individuals
perceive various coronary heart disease factors [203], whilst another
described the relative importance of major adverse cardiac and
cerebrovascular events to be used when analyzing trials [212]. Two
other DCEs were performed on the area of quality improvement; one
investigated how to best disseminate evidence-based practices to
addiction service providers and administrators [205], while the other
was used to investigate which indicators had the greatest impact on
the decisions of health service inspectors concerning the assessment
of quality of mental health care [211]. Other applications included a
study on preferences of health workers in Burkina Faso for health-
insurance payment mechanisms [209]; a study on how respondents
valued mortality risk attributable to climate change reductions [210];
and a study on the preferences for reducing contaminated sites to
reduce the risk for cancer [213].
Fig. 14 Areas of application. For the definitions of categories A, B,
C, D, E, F, G, and H, refer to Table 1
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The use of utility scores (Utility) as the primary out-
come measure is more common, and this has fluctuated
over time. In 1990–2000, 24 % of analyses had utility
scores as the primary outcome measure. The proportion
was 18 % of analyses during 2001–2008, decreasing to
8 % of analyses during 2009–2012.
There is also evidence that the use of odds ratios (Odds)
has fluctuated. In 1990–2000, only 3 % of analyses used
odds ratios as the primary outcome measure. By
2001–2008, the proportion of had more than tripled to
11 % of analyses; the proportion was 8 % in 2009–2012.
Likewise, the use of probability scores (Prob) increased
from 3 % of analyses in 1990–2000 to 13 % of analyses in
2001–2008, before declining to 8 % of analyses during
2009–2012.
Finally, Fig. 15 presents information on ‘other’ outcome
measures used. For the periods 1990–2000 and 2001–2008,
the earlier review authors did not use an ‘other’ category
for the main outcome measure used. However, for this
review, we categorized a substantive number of analyses,
49 % of analyses, in the ‘other’ category. This was mainly
because in 2009–2012 there was a trend to use importance
scores or relative importance of attributes (25 % of anal-
yses) or preference weights (6 % of analyses).
8 Review of Adaptive Conjoint Analysis/Adaptive
Choice Based Conjoint Studies
Having summarized the ACA/ACBC studies in an elec-
tronic supplement (because they use a fundamentally dif-
ferent approach to DCEs), we concluded that it was
difficult to discern major trends in relation to these analyses
across study periods. This is because our PubMed search
unearthed a total of only 26 analyses in 26 papers to review
for the entire review period, 1990–2012. Nonetheless, for
the interesting trends that have been discerned, the details
have been provided in Appendix A of the Electronic
Supplementary Material.
Our searches (Table AI; see the Electronic Supple-
mentary Material for all appendix tables) unearthed no
studies of this type for the period 1990–2000, 14 analyses
for the period 2001–2008, and 12 analyses for the period
2009–2012. In contrast to the DCE literature, most of these
analyses seemed to emanate from the USA, and the surveys
were more likely to be computer administered. The anal-
yses also tended to be designed using Sawtooth software
(Table AII), and no analyses indicated the use of an
alternative software package. Published analyses did not
indicate whether they ever used the main estimation
methods used for DCEs (Table AIII), and all of them either
fell into the ‘other’ or ‘not reported’ categories. Moreover,
validity checks were rarely incorporated into ACA/ACBC
analyses (Table AIV).
9 Discussion
The number of published health-related DCEs has
increased dramatically over the last 2 decades. There has
also been a shift away from UK dominance of health-
related DCEs, with a widening range of countries produc-
ing DCE studies.
The 2001–2008 review [3] noted a wide range of policy
applications for DCEs; this continued during 2009–2012.
In 2001–2008, the valuation of patient experience contin-
ued ‘‘to be the focus of the majority of studies’’ [3]. In
contrast, this declined as the main focus during 2009–2012.
Nevertheless, in 2009–2012, most DCEs continued to
include attributes relating to patient experiences, but
increasingly in order to examine trade-offs between health
outcomes and experience factors. Also health outcomes
and experience factors for respondents groups other than
patients are encompassed by this category (e.g., Category C
analyses).
The 2001–2008 review [3] reported that ‘‘willingness to
pay continued to be a commonly used output from DCEs’’
over that period. However, the present review found evi-
dence that the proportion of DCE studies using either a ‘per
WTP unit’ or a ‘monetary welfare measure’ as their pri-
mary outcome has fallen. This could in part be attributable
to concerns that have been raised in relation to the use of
DCEs to elicit WTP. These include whether estimated
WTP obtained via DCEs may be sensitive to the range
specified for the monetary attribute or the presence or
absence of payment per se [222], or the presence or
absence of a non-zero cost, rather than the level of cost
indicated by the monetary attribute [223]. Other evidence
suggests that the way attributes are ‘framed’ in a DCE
questionnaire may impact upon estimated WTP [113].
Fig. 15 Outcome measures. Prob probability, WTP willingness to
pay
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Furthermore, the hypothetical nature of DCEs can hinder
correct estimates of WTP because respondents will not be
bound by the choices they make [143].
Another issue arises because when estimating marginal
willingness to pay (MWTP), it is commonly assumed that
marginal utility of money is constant and the cost function
is therefore continuous and linear. However, there is reason
to believe that the cost gradient may not be continuous and
linear [115]. Therefore, if WTP is calculated there is a need
to proceed with econometric analysis that assumes more
complex indirect utility functions [123, 124], for example,
using interaction terms between attributes [224], or using
non-linear attribute transformations, such as the squaring of
attributes [225], or taking natural logarithms [226].
In addition to using methods that can be used to identify
unobserved preference heterogeneity, which we discussed
in detail in Sect. 5.4, the issue of segmenting DCE data to
examine the preferences of defined subgroups is sometimes
important. One early analysis [227] segmented the DCE
data according to the severity of symptoms associated with
osteoarthritis, and the importance of a joint ache attribute
was seen to increase in respondents with more severe
symptoms. Other analyses relating to establishing priority
criteria for allocating cadaveric kidney transplants [71, 72]
have provided evidence of statistically significant differ-
ences in preferences between different stakeholder groups.
A major finding to emerge from this research was that
whilst non-ethnic minority patients would prefer to allocate
kidney transplants to recipients with a good tissue match,
ethnic minorities (who would be disadvantaged by use of
such priority criteria) would not. Another interesting ana-
lysis relating to segmentation used segmentation because
‘‘health organizations need to understand whether the same
health treatments, prevention programs, services, and pro-
ducts should be applied to everyone in the relevant popu-
lation or whether different treatments need to be provided
to each of several segments that are relatively homoge-
neous internally but heterogeneous among segments’’
[228]. Segmenting the data to facilitate subgroup analysis
is particularly appropriate if policy-relevant differences in
preferences between defined subgroups might be
applicable.
The use of simulation may be important, when DCEs are
applied, because simulation may enable you to do some-
thing useful with DCE data. For example, in a DCE
relating to junior doctors’ preferences for specialty choice,
it was found that increasing general practitioners (GPs)
wages by $AUS50,000, or increasing opportunities for
procedural or academic work, can increase the number of
junior doctors choosing general practice by between 8 and
13 % [174]. Another example of how useful simulation of
DCE data can be is an analysis that was designed to predict
the place of out-of-hours care. Using DCE data to predict
market shares, it was predicted that a new GP cooperative
could capture about a third of the market, ahead of the
emergency department, the second most preferred service
[183].
In Sect. 5.2, we pointed out that econometric methods
are increasingly being used which can facilitate allowing
respondents to ‘opt-out’ from registering a preference. An
example of why this might be important is apparent from
an analysis relating to colorectal cancer screening [110].
This is because when screening for colorectal cancer, it
was important to give people an ‘opt-out’ response in order
to ensure that the choices respondents faced were realistic.
Similarly, when evaluating two hypothetical smoking
cessation mechanisms, it was important to provide
respondents with an ‘opt-out’ option [128].
This review for 2009–2012 found an increasing trend
towards presenting respondents with more DCE choice
scenarios. Some evidence suggests [203] that later DCE
responses might be more thought through, so this may be a
welcome development. However, the optimal number of
choices presented should ideally be established through
piloting, because it is likely to be a function of the com-
plexity of choices presented. There has also been an
interest in developing approaches to cater for the inclusion
of increased numbers of attributes within DCE designs
[161, 198]. Another development has been a shift away
from self-administered pen/pencil-response DCE ques-
tionnaires towards either interviewer-administered or, more
particularly, computer-administered questionnaires and the
use of internet panels.
The trend towards the increased use of D-efficient DCE
designs noted by de Bekker-Grob et al. [3] has continued.
Although there has been an increase in the proportion of
analyses catering for interactions, main effects designs
remain dominant. Trends away from the use of probit and
random effects probit towards greater use of MNL reflect
the increased use of DCEs incorporating more than two
choices, or two choices plus an opt-out. Recent interest in
the use of models catering for preference heterogeneity is
welcome because when mixed logit or LCM is applied, it
invariably identifies preference heterogeneity, which
otherwise would have been overlooked. That said, one
limitation of the mixed logit approach is that it requires the
imposition of assumptions about the distribution of the
random coefficients. If the distributional assumptions are
not valid, then this can undermine the validity of findings
about preference heterogeneity. LCM has the advantage
over mixed logit that it does not involve the imposition of
such distributional assumptions, but can have the disad-
vantage that it may be more time consuming to implement.
There appears to have been a decline in the use of most
validity tests during 2009–2012, including tests of non-
satiation, transitivity, Sen’s expansion and contraction
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properties, and tests of compensatory decision making. We
might have anticipated a decline in the use of such validity
checks, because the usefulness of the results they yield has
increasingly been called into question [144, 218, 229].
Reassuringly, however, during 2009–2012, there has been
an improvement in the proportion of analyses using qual-
itative methods to enhance DCE processes and results, in
some respects, including the use of qualitative methods to
inform level selection; use of pilot pre-testing question-
naires; and the use of qualitative methods to strengthen
understanding of responses (including debriefing choices).
A remaining cause for concern, however, is that the use of
qualitative methods to inform attribute selection has
declined since 2001–2008. This could lead to increased
likelihood of omitted variable bias affecting DCE results.
The main limitation of this study was that, like the
published review for 2001–2008 [3], we only used PubMed
to source literature. However, as that review noted [3],
when additional searches are conducted on other databases,
it does not markedly affect review findings. So in the
interests of ensuring comparability with data from that
earlier review, we also restricted our searches to the Pub-
Med database.
10 Conclusions
The use of DCEs in healthcare continues to grow dramat-
ically, as does the scope of applications across an
expanding range of countries. There is increasing evidence
that more sophisticated approaches to DCE design and
analytical techniques are improving the quality of final
outputs. That said, recent evidence that the use of quali-
tative methods to inform attribute selection has declined is
of concern.
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